Skip to main content
MBIO
NASDAQ Life Sciences

Mustang Bio Seeks 1-for-5 to 1-for-30 Reverse Split to Hold Nasdaq Listing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.354
Mkt Cap
$2.686M
52W Low
$0.35
52W High
$1.43
52W Position info
1.1% above low
Off High info
75% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MBIO is trading near its 52-week low of $0.35 (1.1% above the low).

Summary

Mustang Bio's preliminary proxy asks shareholders to approve a reverse split of 1-for-5 to 1-for-30, aiming to lift the share price back above Nasdaq's $1.00 minimum bid before the April 12, 2027 deadline. Fortress, with about 56.2% of voting power, has committed to vote in favor.


Key Events · Corporate Governance and Compliance · MBIO

  • Reverse Split Put to Shareholder Vote

    Proposal Four would amend the charter to effect a reverse split of issued and outstanding common stock at a ratio between 1-for-5 and 1-for-30, with the Board choosing the exact ratio and timing before December 21, 2027.

  • Nasdaq Bid Price Still Deficient

    The stock closed at $0.3909 on November 17, 2026, below the $1.00 minimum bid required by Nasdaq Listing Rule 5550(a)(2). The first 180-day window expired October 12, 2026, and the second runs to April 12, 2027.

  • Prior Split Limits Further Grace

    Because a 1-for-50 reverse split was effected January 15, 2025, another split within the two-year window would make the company ineligible for any additional compliance period and trigger a Staff delisting determination, subject to a hearings request.

  • Fortress Controls the Outcome

    Fortress Biotech holds all 250,000 Class A Preferred shares and 536,577 common shares, about 56.2% of total voting power, and has informed the company it will vote FOR all director nominees and Proposals Two, Three and Four.


Analysis · MBIO · Life Sciences

The stakes are simple: Mustang needs a higher share price to keep its Nasdaq listing. At the December 21, 2026 annual meeting, shareholders will vote on a reverse split of between 1-for-5 and 1-for-30, with the Board choosing the exact ratio and timing any time before December 21, 2027. The stock closed at $0.3909 on November 17, 2026, far below Nasdaq's $1.00 minimum bid. The company already used its first 180-day window, which expired October 12, 2026, and is now running the second, ending April 12, 2027. One hard constraint stands out: because Mustang already did a 1-for-50 reverse split on January 15, 2025, another split inside the two-year window would leave it ineligible for any further compliance period and expose it to a Staff delisting determination. Approval is effectively assured—Fortress Biotech holds roughly 56.2% of the voting power and has said it will vote for all proposals. The real question is whether a higher nominal share price actually attracts buyers. The proxy also covers routine items: seven director nominees, KPMG ratification, and a say-on-pay vote.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MBIO was trading at $0.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.35 to $1.43. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MBIO - Latest Insights

MBIO
Nov 05, 2026, 4:09 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.394
Real-time Price: $0.2901 info
Change: -$0.1039 (-26%) info
Market Cap: $2.686M info
MBIO
Oct 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3861
Real-time Price: $0.2901 info
Change: -$0.096 (-25%) info
Market Cap: $2.686M info
MBIO
May 05, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.774
Real-time Price: $0.2901 info
Change: -$0.4839 (-63%) info
Market Cap: $2.686M info
MBIO
Apr 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.770
Real-time Price: $0.2901 info
Change: -$0.4799 (-62%) info
Market Cap: $2.686M info
MBIO
Mar 19, 2026, 4:05 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.8499
Real-time Price: $0.2901 info
Change: -$0.5598 (-66%) info
Market Cap: $2.686M info